HeartSciences (HSCS) Return on Capital Employed (2022 - 2026)
HeartSciences (HSCS) reported Return on Capital Employed of 311.08% for Q1 2026, down 4881.0% on a YoY basis from 6.51% in Q1 2025, and down 75.57% quarter-over-quarter from 177.18% in Q4 2025.
HeartSciences (HSCS) Return on Capital Employed (2022 - 2026) Analysis & Trends
HeartSciences has reported Return on Capital Employed for 5 years, with the latest figure at 311.08% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 4881.0% year-over-year to 311.08%; the trailing twelve-month figure through Jan 2026 stood at 311.08% (down 4881.0% YoY), and the FY2025 full-year result was 264.34%, down 12854.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 311.08%, down from 177.18% in the prior quarter.
- The five-year high for Return on Capital Employed was 554.21% in Q4 2023, with the low at 662.81% in Q2 2025.
- Historically, Return on Capital Employed has averaged 232.32% across 5 years, with a median of 262.27% in 2025.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 86370 bps — and 2024, when it sank 71368 bps.
- HeartSciences' Return on Capital Employed stood at 309.49% in 2022, then soared by 279 bps to 554.21% in 2023, then tumbled by 129 bps to 159.47% in 2024, then retreated by 11 bps to 177.18% in 2025, then tumbled by 76 bps to 311.08% in 2026.
- The last three Return on Capital Employed figures came in at 311.08% (Q1 2026), 177.18% (Q4 2025), and 352.01% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | -311.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -311.08% |
| Oct 31, 2025 | -177.18% |
| Jul 31, 2025 | -352.01% |
| Apr 30, 2025 | -662.81% |
| Jan 31, 2025 | -262.27% |
| Oct 31, 2024 | -159.47% |
| Jul 31, 2024 | -94.07% |
| Apr 30, 2024 | -75.07% |
| Jan 31, 2024 | -123.49% |
| Oct 31, 2023 | 554.21% |
| Jul 31, 2023 | -575.60% |
| Apr 30, 2023 | -394.16% |
| Jan 31, 2023 | -303.36% |
| Oct 31, 2022 | -309.49% |
| Jul 31, 2022 | -239.03% |